Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Consolidated Net Income (2019 - 2025)

Historic Consolidated Net Income for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$19.5 million.

  • Outset Medical's Consolidated Net Income rose 2397.61% to -$19.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$81.7 million, marking a year-over-year increase of 3619.66%. This contributed to the annual value of -$81.7 million for FY2025, which is 3619.66% up from last year.
  • As of Q4 2025, Outset Medical's Consolidated Net Income stood at -$19.5 million, which was up 2397.61% from -$17.8 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Consolidated Net Income registered a high of -$17.8 million during Q3 2025, and its lowest value of -$46.2 million during Q3 2023.
  • In the last 5 years, Outset Medical's Consolidated Net Income had a median value of -$35.7 million in 2022 and averaged -$33.9 million.
  • Per our database at Business Quant, Outset Medical's Consolidated Net Income tumbled by 4539.95% in 2021 and then surged by 4618.62% in 2025.
  • Outset Medical's Consolidated Net Income (Quarter) stood at -$41.2 million in 2021, then fell by 0.51% to -$41.4 million in 2022, then rose by 6.86% to -$38.6 million in 2023, then surged by 33.58% to -$25.6 million in 2024, then rose by 23.98% to -$19.5 million in 2025.
  • Its Consolidated Net Income stands at -$19.5 million for Q4 2025, versus -$17.8 million for Q3 2025 and -$18.5 million for Q2 2025.